X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Aventis Pharma with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs ADCOCK INGRAM (S. Africa) - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 SANOFI INDIA   ADCOCK INGRAM
EQUITY SHARE DATA
    SANOFI INDIA
Dec-17
ADCOCK INGRAM
Jun-14
SANOFI INDIA/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs4,945365-   
Low Rs3,901264-   
Sales per share (Unadj.) Rs1,081.8108.7-  
Earnings per share (Unadj.) Rs141.6-27.4-  
Cash flow per share (Unadj.) Rs185.9-22.7-  
Dividends per share (Unadj.) Rs33.000-  
Dividend yield (eoy) %0.70-  
Book value per share (Unadj.) Rs868.885.3-  
Shares outstanding (eoy) m23.03168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.12.9 141.3%   
Avg P/E ratio x31.2-11.5 -272.1%  
P/CF ratio (eoy) x23.8-13.9 -171.7%  
Price / Book Value ratio x5.13.7 138.1%  
Dividend payout %23.30-   
Avg Mkt Cap Rs m101,86253,081 191.9%   
No. of employees `0003.24.3 75.4%   
Total wages/salary Rs m3,6853,331 110.6%   
Avg. sales/employee Rs Th7,691.94,273.4 180.0%   
Avg. wages/employee Rs Th1,137.7776.0 146.6%   
Avg. net profit/employee Rs Th1,006.5-1,076.8 -93.5%   
INCOME DATA
Net Sales Rs m24,91418,346 135.8%  
Other income Rs m807128 628.2%   
Total revenues Rs m25,72118,474 139.2%   
Gross profit Rs m5,372-3,179 -169.0%  
Depreciation Rs m1,022792 129.1%   
Interest Rs m11497 2.2%   
Profit before tax Rs m5,146-4,339 -118.6%   
Minority Interest Rs m0-12 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,886271 695.6%   
Profit after tax Rs m3,260-4,623 -70.5%  
Gross profit margin %21.6-17.3 -124.4%  
Effective tax rate %36.6-6.2 -586.5%   
Net profit margin %13.1-25.2 -51.9%  
BALANCE SHEET DATA
Current assets Rs m14,43213,437 107.4%   
Current liabilities Rs m6,0107,560 79.5%   
Net working cap to sales %33.832.0 105.5%  
Current ratio x2.41.8 135.1%  
Inventory Days Days61111 54.9%  
Debtors Days Days28124 23.0%  
Net fixed assets Rs m7,9917,832 102.0%   
Share capital Rs m23085 270.4%   
"Free" reserves Rs m19,7780-   
Net worth Rs m20,00814,399 139.0%   
Long term debt Rs m05,060 0.0%   
Total assets Rs m27,77027,201 102.1%  
Interest coverage x468.8-7.7 -6,063.2%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 133.0%   
Return on assets %11.8-15.2 -77.7%  
Return on equity %16.3-32.1 -50.8%  
Return on capital %25.8-19.8 -130.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m1,0490-   
CASH FLOW
From Operations Rs m4,3511,566 277.9%  
From Investments Rs m-787-481 163.7%  
From Financial Activity Rs m-1,8844,592 -41.0%  
Net Cashflow Rs m1,6805,678 29.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.04 Rs / ZAR

Compare SANOFI INDIA With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare SANOFI INDIA With: FULFORD INDIA  CADILA HEALTHCARE  AJANTA PHARMA  ELDER PHARMA  LUPIN LTD  



Today's Market

Sensex Ends 331 Points Higher; Oil & Gas Stocks Witness Buying(Closing)

After opening on a negative note, share markets in India witnessed buying interest during closing hours and ended the day on a positive note.

Related Views On News

SANOFI INDIA Announces Quarterly Results (2QFY19); Net Profit Up 2.5% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

SANOFI INDIA Announces Quarterly Results (1QFY19); Net Profit Up 35.1% (Quarterly Result Update)

Jul 27, 2018 | Updated on Jul 27, 2018

For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

3 Big Money Makers to Round Out Your 2018 Portfolio(Profit Hunter)

Oct 31, 2018

The market is offering many strong opportunities in the small cap space right now. Don't miss out. This is the time to get rich.

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

Insider Buying: These Owner Operators Are Taking Advantage of the Correction(Chart Of The Day)

Nov 2, 2018

We believe insider buying is one of the strongest smart money indicators.

Are You Among The 35% Parents Who Will Not Be Able To Finance Their Child's Future?(Outside View)

Nov 1, 2018

PersonalFN explains the importance of being prepared for your child's future.

Are Fund Houses Opening Up Their NFO Factories Again?(Outside View)

Nov 2, 2018

PersonalFN sheds light on FY 2018-19 so far, the mutual fund industry has collectively launched 84 New Fund Offers (NFOs), of which some are still open for subscription.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Nov 13, 2018 (Close)

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS